JSGCX
Price
$24.82
Change
+$0.28 (+1.14%)
Updated
Jan 17 closing price
Net Assets
1.71B
VIGRX
Price
$214.09
Change
+$2.76 (+1.31%)
Updated
Jan 17 closing price
Net Assets
284.41B
Ad is loading...

JSGCX vs VIGRX

Header iconJSGCX vs VIGRX Comparison
Open Charts JSGCX vs VIGRXBanner chart's image
JHancock U.S. Growth C
Price$24.82
Change+$0.28 (+1.14%)
VolumeN/A
Net Assets1.71B
Vanguard Growth Index Investor
Price$214.09
Change+$2.76 (+1.31%)
VolumeN/A
Net Assets284.41B
JSGCX vs VIGRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JSGCX vs. VIGRX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSGCX is a Buy and VIGRX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGRX has more cash in the bank: 284B vs. JSGCX (1.71B). VIGRX pays higher dividends than JSGCX: VIGRX (0.43) vs JSGCX (0.00). JSGCX was incepted earlier than VIGRX: JSGCX (10 years) vs VIGRX (32 years). JSGCX is a more actively managed with annual turnover of: 103.00 vs. VIGRX (5.00). JSGCX has a lower initial minimum investment than VIGRX: JSGCX (1000) vs VIGRX (3000). VIGRX annual gain was more profitable for investors over the last year : 31.98 vs. JSGCX (18.19). VIGRX return over 5 years is better than : 116.73 vs. JSGCX (28.47).
JSGCXVIGRXJSGCX / VIGRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years32 years-
Gain YTD2.0981.325158%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets1.71B284B1%
Annual Yield % from dividends0.000.43-
Returns for 1 year18.1931.9857%
Returns for 3 years11.8541.4429%
Returns for 5 years28.47116.7324%
Returns for 10 years58.59306.3819%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PEB13.750.05
+0.36%
Pebblebrook Hotel Trust
AZN66.60-0.31
-0.46%
AstraZeneca PLC
CRT10.28-0.05
-0.48%
Cross Timbers Royalty Trust
ARCT16.79-0.22
-1.29%
Arcturus Therapeutics Holdings
ASND128.13-3.49
-2.65%
Ascendis Pharma A/S